Aqr Capital Management LLC Magenta Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $34,241 - $108,724	-35,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $28,136 - $57,707	11,034 Added 45.47%	35,300 $102,000
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $59,685 - $112,230	-13,473 Reduced 35.7%	24,266 $107,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $229,075 - $373,238	37,739 New	37,739 $275,000
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $200,416 - $350,074	-26,164 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.1 - $7.94 $14,408 - $18,754	-2,362 Reduced 8.28%	26,164 $205,000
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $873 - $1,197	-134 Reduced 0.47%	28,526 $194,000
Q2 2020 Aug 17, 2020	BUY	$6.18 - $10.76 $108,193 - $188,375	17,507 Added 156.97%	28,660 $215,000
Q1 2020 May 15, 2020	BUY	$6.03 - $15.24 $67,252 - $169,971	11,153 New	11,153 $70,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.